New combo aims to control prostate cancer without harsh hormone therapy
NCT ID NCT06574880
Summary
This study is testing whether a targeted drug called Pluvicto can be used instead of long-term hormone therapy when combined with radiation for men with locally advanced prostate cancer. The goal is to control the cancer while avoiding the difficult side effects of hormone therapy and preserving quality of life. Participants will receive Pluvicto injections and a short course of radiation over several weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT NEOPLASM OF PROSTATE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospitals Cleveland Medical Center Seidman Cancer Center, Case Comprehensive Cancer Center
RECRUITINGCleveland, Ohio, 44106, United States
Conditions
Explore the condition pages connected to this study.